- Home
- AMPH vs WT Comparison
AMPH vs WT Comparison
Compare AMPH & WT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMPH
- WT
- Stock Information
- Founded
- AMPH 1996
- WT 1985
- Country
- AMPH United States
- WT United States
- Employees
- AMPH N/A
- WT N/A
- Industry
- AMPH Biotechnology: Pharmaceutical Preparations
- WT Investment Bankers/Brokers/Service
- Sector
- AMPH Health Care
- WT Finance
- Exchange
- AMPH Nasdaq
- WT Nasdaq
- Market Cap
- AMPH 1.1B
- WT 1.2B
- IPO Year
- AMPH 2014
- WT N/A
- Fundamental
- Price
- AMPH $23.30
- WT $9.43
- Analyst Decision
- AMPH Hold
- WT Buy
- Analyst Count
- AMPH 5
- WT 7
- Target Price
- AMPH $38.00
- WT $12.21
- AVG Volume (30 Days)
- AMPH 566.0K
- WT 1.3M
- Earning Date
- AMPH 05-07-2025
- WT 05-02-2025
- Dividend Yield
- AMPH N/A
- WT 1.27%
- EPS Growth
- AMPH N/A
- WT N/A
- EPS
- AMPH 2.77
- WT 0.37
- Revenue
- AMPH $730,659,000.00
- WT $438,981,000.00
- Revenue This Year
- AMPH $1.48
- WT $6.78
- Revenue Next Year
- AMPH $5.97
- WT $3.95
- P/E Ratio
- AMPH $8.47
- WT $25.94
- Revenue Growth
- AMPH 8.05
- WT 20.66
- 52 Week Low
- AMPH $22.64
- WT $7.47
- 52 Week High
- AMPH $53.96
- WT $12.45
- Technical
- Relative Strength Index (RSI)
- AMPH 39.25
- WT 63.21
- Support Level
- AMPH $23.30
- WT $9.03
- Resistance Level
- AMPH $25.36
- WT $9.91
- Average True Range (ATR)
- AMPH 0.86
- WT 0.23
- MACD
- AMPH 0.10
- WT 0.08
- Stochastic Oscillator
- AMPH 1.66
- WT 66.78
About AMPH Amphastar Pharmaceuticals Inc.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
About WT WisdomTree Inc.
WisdomTree Inc is a financial innovator, offering a well-diversified suite of exchange-traded products (ETPs), models and solutions. It offers a broad range of ETFs and exchange-traded products (ETPs). The firm also engages in developing next-generation digital products and structures, including digital funds and tokenized assets, as well as its blockchain-native digital wallet, WisdomTree Prime. The Company conducts business under a single operating segment as an ETP sponsor and asset manager.